Does the lipid membrane composition of arsonoliposomes affect their anticancer activity? A cell culture study

Molecular Nutrition and Food Research

Volumn 53, Issue 5, 2009, Pages 592-599

  Zagana, Paraskevi ^a   Haikou, Maria ^a   Giannopoulou, Eleftheria ^b   Ioannou, Panayiotis V ^a   Antimisiaris, Sophia G ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c INSTITUTE OF CHEMICAL ENGINEERING SCIENCES   (Greece)

Author keywords

Anticancer; Arsenic; Arsonolipid; Arsonoliposome; Lipid composition

Indexed keywords

ANTINEOPLASTIC AGENT; LIPID; LIPOSOME; ORGANOARSENIC DERIVATIVE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; HUMAN;

ANTINEOPLASTIC AGENTS; ARSENICALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; LIPIDS; LIPOSOMES;

EID: 67649111455     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700474     Document Type: Article

References (24)

1. Fatouros, D., Gortzi, O., Klepetsanis, P., Antimisiaris, S. G., et al., Preparation and properties of arsonolipid containing liposomes. Chem. Phys. Lipids 2001, 109, 75-89.
2. Fatouros, D., Ioannou, P. V., Antimisiaris, S. G., Novel nano-sized arsenic containing vesicles for drug delivery: Arsonoli-posomes. J. Nanosci. Nanotechnol. 2006, 6, 2618-2687.
3. Gortzi, O., Papadimitriou, E., Kontoyannis, C., Antimisiaris, S. G., Ioannou, P. V., Arsonoliposomes, a Novel class of arsenic-containing liposomes: Effect of palmitoyl-arsonoli-pid-containing liposomes on the viability of cancer and normal cells in culture. Pharm. Res. 2002, 19, 79-86.
4. Gortzi, O., Papadimitriou, E., Antimisiaris, S. G., Ioannou, P. V., Cytotoxicity of arsonolipid containing liposomes towards cancer and normal cells in culture: Effect of arsonolipid acyl chain length. Eur. J. Pharm. Sci. 2003, 18, 175-183.
5. Antimisiaris, S. G., Ioannou, P. V., Loiseau, P. M., In vitro antileishmanial and trypanocidal activities of arsonolipo-somes and preliminary in vivo distribution. J. Pharm. Pharmacol. 2003, 55, 647-652.
6. Piperoudi, S., Ioannou, P. V., Frederik, P., Antimisiaris, S. G., Arsonoliposomes: Effect of lipid composition on their stability. J. Lipos. Res. 2005, 15, 187-197.
7. Piperoudi, S., Fatouros, D., Ioannou, P. V., Frederik, P., Anti-misiaris, S. G., Incorporation of PEG-lipids in arsonolipo-somes can produce highly stable arsenic-containing vesicles of specific lipid composition. Chem. Phys. Lipids 2006, 139, 96-106.
8. Antimisiaris, S. G, Klepetsanis, P., Zachariou, V., Giannopou-lou, E., Ioannou, P. V., In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice. Int. J. Pharm. 2005, 289, 151-158.
9. Zagana, P., Haikou, M., Klepetsanis, P., Giannopoulou, E., et al., In vivo distribution of arsonoliposomes: Effect of vesicle lipid composition. Int. J. Pharm. 2008, 347, 86-92.
10. Zagana, P., Klepetsanis, P., Ioannou, P. V., Loiseau, P. M., Antimisiaris, S. G., Trypanocidal activity of arsonolipo-somes: Effect of vesicle lipid composition, Biomed. Pharmacother. 2007, 61, 499-504.
11. Kigawa, J., Minagawa, Y., Kanamori, Y., Itamochi, H., et al., Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovar-ian cancer. Cancer 1998, 82, 697-702.
12. Haikou, M., Zagana, P., Ioannou, P. V., Antimisiaris, S. G., Arsonoliposome Interaction with thiols. Effect of pegylation and arsonolipid content on their integrity during incubation in the presence of glutathione. J. Nanosci. Nanotechnol. 2006, 6, 2974-2978.
13. Timotheatou, D., Ioannou, P. V., Scozzafava, A., Briganti, F., Supuran, C. T., Carbonic anhydrase interaction with lipo-thioasrenites: A novel class of isozymes I and II inhibitors. Met. Based Drugs 1996, 3, 263-268.
14. Jaffe, E. A., Nachman, R. L., Becker, C. G., Minick, C. R., Culture of human endothelial cells derived from umbilical veins. Identification by morphological and immunological criteria. J. Clin. Invest. 1973, 52, 2745-2756.
15. Tsivgoulis, G. M., Sotiropoulos, D. N., Ioannou, P. V., 1,2-Dihydroxypropyl-3-arsonic acid: A key intermediate for arsonolipids. Phosphorus Sulfur Silicon 1991, 57, 189-193.
16. Tsivgoulis, G. M., Sotiropoulos, D. N., Ioannou, P. V., rac-1,2-Diacylo-xypropyl-3-arsonic acids: Arsonolipid analogues of phosphonolipids. Phosphorous Sulfur Silicon 1991, 63, 329-334.
17. Serves, S. V., Sotiropoulos, D. N., Ioannou, P. V., Jain, M. K., Synthesis of (R)- and (S)-1,2-diacyloxypropyl-3-arsonic acids: Optically active arsonolipids. Phosphorous Sulfur Silicon 1992, 71, 99-105.
18. Serves, S. V., Sotiropoulos, D. N., Ioannou, P. V., Jain, M. K., One pot synthesis of arsonolipid via thioarsenite precursors. Phosphorous Sulfur Silicon 1993, 81, 181-190.
19. Stewart, J. C. M., Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 1980, 104, 10-14.
20. Desaulniers, J. A. H., Sturgeon, R. E., Berman, S. S., Atomic absorption determination of trace metals in marine sediments and biological tissues using a stabilized temperature platform furnace. At. Spectrosc. 1985, 6, 125-127.
21. Devalla, S., Feldmann, J., Determination of lipid-soluble arsenic species in seaweed-eating sheep from Orkney. Appl. Organomet. Chem. 2003, 17, 906-912.
22. Kokkona, M., Kallinteri, P., Fatouros, D., Antimisiaris, S. G., Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases:Effect of lipid composition. Eur. J. Pharm. Sci. 2000, 9, 245-252.
23. Mosmann, T. J., Rapid colorimetric assay for cellular growth and survival- Application to proliferation and cytotoxicity assays. Immunol. Methods 1983, 65, 55-63.
24. Baumgartner, M., Sturlan, S., Roth, E., Wessner, B., Bachleit-ner-Hofmann, T., Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cell. Int. J. Cancer 2004, 112, 707-712.